Satellos Bioscience Inc. (MSCL.TO)

CAD 0.89

(-4.3%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - 25 Thousand
Cost of Revenue 8.81 Million 3.73 Million 119.91 Thousand 48.16 Thousand 1.28 Million
Gross Profit -8.81 Million -3.73 Million -119.91 Thousand -48.16 Thousand -1.25 Million
Operating Expenses 6.64 Million 8.42 Million 4.7 Million 1.42 Million 743.79 Thousand
Selling, General and Administrative Expenses 6.05 Million 3.96 Million 1.44 Million 182.36 Thousand 1.23 Million
Research and Development Expenses 8.81 Million 3.73 Million 2 Million 892.78 Thousand 1.28 Million
Other Expenses - -48.67 Thousand -43.84 Thousand -75 Thousand -
Cost and Expenses 15.46 Million 8.42 Million 4.7 Million 1.47 Million 2.02 Million
Operating Income -15.46 Million -8.42 Million -4.73 Million -1.54 Million -1.99 Million
Interest Expense 177 Thousand - 985.33 Thousand 23.04 Thousand -
Income Tax Expense - 5000.00 941.49 Thousand -51.95 Thousand -
Earnings before Tax -15.88 Million -11.31 Million -15.5 Million -1.57 Million -1.98 Million
Net Income -15.88 Million -11.32 Million -15.5 Million -1.57 Million -1.98 Million
Earnings Per Share Basic -0.18 -0.32 -0.64 -0.05 -0.18
Earnings Per Share Diluted -0.18 -0.32 -0.64 -0.05 -0.18
Weighted Average Shares Outstanding 86.4 Million 35.68 Million 24.07 Million 32.86 Million 10.91 Million
Weighted Average Shares Outstanding (Diluted) 86.4 Million 35.68 Million 24.07 Million 32.86 Million 10.91 Million
Gross Margin - - - - -50.30
EBIT Margin - - - - -79.95
Profit Margin - - - - -79.54
EBITDA -15.7 Million -8.09 Million -4.6 Million -1.6 Million -1.99 Million
Earnings Before Tax Margin - - - - -79.98

Income Statement Charts